After performing log-rank tests in the TCGA SARC cohort and validating these good-prognosis-related genes with the GEO dataset GSE17679, we extracted information indicating that NR1H3, VAMP5, GIMAP2, GBP2, HLA-E and CRIP1 were highly expressed in the immune microenvironment and were most significantly associated with predicting good outcomes in sarcoma patients (Figure 3D–3I, Supplementary Figure 2). The gene discussed is GIMAP2; the disease is sarcoma.